Your browser doesn't support javascript.
loading
Nanotechnology in drug and gene delivery.
Hamimed, Selma; Jabberi, Marwa; Chatti, Abdelwaheb.
Afiliación
  • Hamimed S; Laboratory of Biochemistry and Molecular Biology, Faculty of Sciences of Bizerte, University of Carthage, CP 7021, Jarzouna, Tunisia. salma.hamimed@fsb.rnu.tn.
  • Jabberi M; Departement of Biology, Faculty of Exact Sciences, Natural and Life Sciences, Chaikh Larbi Tebessi University, Tebessa, Algeria. salma.hamimed@fsb.rnu.tn.
  • Chatti A; Laboratory of Biochemistry and Molecular Biology, Faculty of Sciences of Bizerte, University of Carthage, CP 7021, Jarzouna, Tunisia.
Naunyn Schmiedebergs Arch Pharmacol ; 395(7): 769-787, 2022 07.
Article en En | MEDLINE | ID: mdl-35505234
ABSTRACT
Over the last decade, nanotechnology has widely addressed many nanomaterials in the biomedical area with an opportunity to achieve better-targeted delivery, effective treatment, and an improved safety profile. Nanocarriers have the potential property to protect the active molecule during drug delivery. Depending on the employing nanosystem, the delivery of drugs and genes has enhanced the bioavailability of the molecule at the disease site and exercised an excellent control of the molecule release. Herein, the chapter discusses various advanced nanomaterials designed to develop better nanocarrier systems used to face different diseases such as cancer, heart failure, and malaria. Furthermore, we demonstrate the great attention to the promising role of nanocarriers in ease diagnostic and biodistribution for successful clinical cancer therapy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_malaria Asunto principal: Nanopartículas / Neoplasias Límite: Humans Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Túnez

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_malaria Asunto principal: Nanopartículas / Neoplasias Límite: Humans Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Túnez
...